The article titled Understanding Therapy Services & When to Seek Them features insights from Rehabilitation Expert Kelly ...
FDA Approves KYGEVVI® (doxecitine and doxribtimine), the First and Only Treatment for Adults and Children Living with Thymidine Kinase 2 deficiency (TK2d), a Rare and Devastating Mitochondrial Disease ...
Twenty-four of 58 adults (41%) and 29 of 56 children (52%) had a BICR-confirmed objective response during the 24-cycle treatment phase; in addition, two adults and one child had confirmed responses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results